QTc and autonomic neuropathy in diabetes: Effects of acute hyperglycaemia and n-3 PUFA

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 10, 2007, Pages 712-718

  Santini, Vanina ^a   Ciampittiello, Giuseppina ^a   Gigli, Fabrizio ^a   Bracaglia, Daniela ^a   Baroni, Alessandra ^a   Cicconetti, Elena ^a   Verri, Cristian ^a   Gambardella, Sergio ^a   Frontoni, Simona ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Autonomic neuropathy; Cardiac dysfunction; Cardiovascular disease; Sympathetic

Indexed keywords

OMEGA 3 FATTY ACID;

ARTICLE; AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC NEUROPATHY; ELECTROCARDIOGRAPHY; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART FUNCTION TEST; HEART RATE; HUMAN; HYPERGLYCEMIA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; ELECTROCARDIOGRAPHY; FATTY ACIDS, OMEGA-3; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEART FUNCTION TESTS; HEART RATE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED;

EID: 36049040325     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.09.006     Document Type: Article

References (26)

1. Stamler J., Vaccaro O., Neaton J.D., Wentworth D., and for the Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16 (1993) 434
2. Suarez G.A., Clark V.M., Norell J.E., Kottke T.E., Callahan M.J., O'Brien P.C., et al. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. Diabetes Care 28 (2005) 440-442
3. Spallone V., Maiello M.R., Cicconetti E., Pannone A., Barini A., Gambardella S., et al. Factors determining the 24 h blood pressure profile in normotensive patients with type 1 and type 2 diabetes. J Hum Hypertens 15 (2000) 239-246
4. Yeo C.K., Hapizah M.N., Khalid B.A., Wan Nazainimoon W.M., and Khalid Y. The comparison of QT dispersion and 24 hour blood pressure monitoring amongst diabetic patients with and without microalbuminuria. Diabetologia 48 (2005) 164-171
5. Witte D.R., Tesfaye S., Chaturvedi N., Eaton S.E., Kempler P., and Fuller J.H. EURODIAB Prospective Complications Study Group. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Heart 91 (2005) 44-50
6. Marfella R., Nappo F., De Angelis L., Paolisso G., Tagliamonte M.R., and Giugliano D. Haemodinamic effects of acute hyperglycaemia in type 2 diabetic patients. Diabetes Care 23 (2000) 658-663
7. Marfella R., Nappo F., De Angelis L., Siniscalchi M., Rossi F., and Giugliano D. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 43 (2000) 571-575
8. Nettleton J.A., and Katz R. n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J Am Diet Assoc 105 (2005) 428-440
9. O'Brien I.A., McFadden J.P., and Corrall R.J. The influence of autonomic neuropathy on mortality in insulin-dependent diabetes. Q J Med 79 (1991) 495-502
10. Hanefeld M., Fischer S., Julius U., Schulze J., Schwanebeck U., Schmechel H., et al. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39 (1996) 1577
11. Gambardella S., Frontoni S., Spallone V., Maiello M.R., Civetta E., Lanza G., et al. Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy. Am J Hypertens 6 (1993) 97-102
12. O'Brien E., Mee F., Atkins N., and O'Malley K. Accuracy of the Spacelabs 90207 determined by the British Hypertension Society protocol. J Hypertens 9 (1991) 573-574
13. Frontoni S., Pellegrinotti M., Bracaglia D., Farrace S., Caselli A., Baroni A., et al. Hyperinsulinaemia in offspring of type 2 diabetic patients: impaired response of carbohydrate metabolism, but preserved cardiovascular response. Diabet Med 17 (2000) 606-611
14. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J 17 (1996) 354-381
15. Bonora E., Formentini G., Calcaterra F., Lombardi S., Merini F., Zenari L., et al. HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the VERONA Diabetes Complications Study. Diabetes Care 25 (2002) 1135
16. The DECODE study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality. Comparison of fasting and 2-h diagnostic criteria. Arch Intern Med 161 (2001) 397
17. Schichiri M., Kishikawa H., Ohkubo Y., and Wake N. Long-term results of the Kunamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care 23 Suppl. 2 (2000) B21
18. Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., and Laakso M. STOP-NIDDM Trial Research Group. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290 (2003) 486
19. Ceriello A. Postprandial hyperglycaemia and diabetes complications. Is it time to treat?. Diabetes 54 (2005) 1-7
20. Frontoni S., Bracaglia D., and Gigli F. Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes. Nutr Metab Cardiovasc Dis 15 (2005) 441-449
21. Vincent A.M., Russel J.W., Low P., and Feldman E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25 (2004) 612-628
22. Takebayashi K., Aso Y., Matsutomo R., Wakabayashi S., and Inukai T. Association between the corrected QT intervals and combined intima-medial thickness of the carotid artery in patients with type 2 diabetes. Metabolism 53 (2004) 1152-1157
23. Nagata K., Sasaki E., Goda K., Yamamoto N., Narabayashi I., and Hanafusa T. Differences in heart rate variability in non-hypertensive diabetic patients correlate with the presence of underlying cerebrovascular disease. Clin Physiol Funct Imaging 26 (2006) 92-98
24. Marchioli R., Barzi F., Bomba E., Chieffo C., Di Gregorio D., Di Mascio R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction. Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
25. Burr M.I., Fehily A.M., and Gilbert J.F. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet And Reinfarction Trial (DART). Lancet 2 (1989) 757-761
26. Raitt M.H., Connor W.E., Morris C., Kron J., Halperin B., Chugh S.S., et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomised controlled trial. JAMA 293 23 (2005) 2884-2891